-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Persistent or recurrent reflux symptoms after Nissen fundoplication can be frustrating for patients and challenging for clinicians. Heartburn, regurgitation, chest discomfort, cough, throat clearing, and difficulty swallowing do not always indicate that the wrap has failed. Symptoms may reflect acid reflux, non-acid reflux, gas-bloat syndrome, a motility disorder, or an unrelated condition.
A careful, evidence-based assessment is therefore essential before increasing medication or considering repeat surgery. The esophageal disease research and multidisciplinary perspective highlighted by the International Society for Diseases of the Esophagus (ISDE) provide a useful framework for evaluating complex postoperative cases.
Reflux is often described as refractory when symptoms continue despite appropriate acid-suppressive treatment. After fundoplication, however, symptoms may persist even when acid exposure is normal. Some patients have functional heartburn, reflux hypersensitivity, rumination, supragastric belching, or laryngeal conditions that mimic gastroesophageal reflux disease.
The first step is to review the original diagnosis, the type of fundoplication, symptom response after surgery, medication use, and the timing of recurrent symptoms. A return of heartburn several years after effective surgery has different implications from immediate postoperative dysphagia or regurgitation.
An upper endoscopy can identify esophagitis, recurrent hiatal hernia, Barrett’s esophagus, peptic stricture, retained food, or an overly tight or displaced wrap. A contrast esophagram may show abnormal emptying, wrap migration, paraesophageal hernia, or obstruction that is not obvious during endoscopy.
High-resolution esophageal manometry is especially important when dysphagia, chest pain, or regurgitation is prominent. It evaluates the esophageal body, lower esophageal sphincter, and resistance created by the fundoplication. These findings help distinguish a mechanical problem from achalasia, absent contractility, or another motility disorder.
Ambulatory reflux monitoring can determine whether symptoms correlate with abnormal acid or non-acid exposure. Testing off proton pump inhibitors is generally useful when the diagnosis of reflux remains uncertain. Testing on medication may be appropriate when established reflux disease is suspected but symptoms continue during treatment.
Impedance-pH monitoring can detect weakly acidic and non-acid reflux, while symptom association analysis helps establish whether episodes correspond with cough, chest pain, or regurgitation. This distinction prevents unnecessary revision surgery in patients whose symptoms are not caused by reflux.
| Finding | Possible explanation | Typical next step |
|---|---|---|
| Abnormal acid exposure with intact wrap | Recurrent reflux or inadequate acid control | Review medication, anatomy, and reflux pattern |
| Recurrent hiatal hernia or slipped wrap | Mechanical failure | Specialist surgical assessment |
| Normal reflux testing with typical symptoms | Functional heartburn or hypersensitivity | Neuromodulation and behavioral treatment |
| Dysphagia with high outflow resistance | Tight or distorted fundoplication | Endoscopic or surgical evaluation |
| Normal acid exposure with excessive belching | Supragastric belching or aerophagia | Behavioral therapy and speech therapy assessment |
When testing confirms ongoing acid reflux, a proton pump inhibitor may be optimized by checking adherence and dosing before meals. An H2-receptor antagonist at night can sometimes help selected patients with nocturnal symptoms, although tolerance may develop. Alginate preparations can provide a mechanical barrier for breakthrough symptoms, while treatment should remain tailored to documented disease.
Dietary and behavioral measures can reduce symptom burden. Smaller meals, avoiding meals close to bedtime, weight management when appropriate, limiting tobacco exposure, and identifying individual triggers may help. Patients with rumination, excessive belching, or reflux hypersensitivity may benefit from diaphragmatic breathing, cognitive behavioral therapy, or specialized speech therapy.
Redo fundoplication is most appropriate when objective testing demonstrates a correctable anatomical problem and symptoms are consistent with that finding. Revision procedures can involve repair of a recurrent hiatal hernia, takedown and reconstruction of the wrap, or conversion to another operation in selected cases.
Reoperative surgery carries greater risks than primary fundoplication, including bleeding, vagal nerve injury, esophageal or gastric injury, recurrent hernia, gas-bloat symptoms, and persistent dysphagia. Assessment by an experienced foregut surgeon, supported by endoscopy, contrast imaging, manometry, and reflux monitoring, is important before proceeding.
Management is strongest when gastroenterologists, foregut surgeons, radiologists, dietitians, and behavioral health professionals work from the same diagnostic information. Symptoms should be tracked alongside objective findings rather than treated in isolation. New or progressive dysphagia, vomiting, gastrointestinal bleeding, anemia, unintentional weight loss, or severe chest pain requires prompt medical evaluation.
Patients with Barrett’s esophagus need surveillance based on current clinical guidance, while those taking long-term acid suppression should receive individualized medication reviews. The educational materials and scientific discussions associated with ISDE 2021 underscore the value of structured assessment in complex esophageal disease.
Refractory reflux after Nissen fundoplication should be managed as a diagnostic problem rather than assumed surgical failure. Objective testing can reveal whether the best next step is medication adjustment, behavioral therapy, endoscopic treatment, or carefully selected reoperation. Clinicians and patients can use reputable esophageal disease education from professional societies such as ISDE to support informed, specialist-led care.